Brought to you by 
RefleXion Medical closes $46mm Series B round; round extended to $52mm
17 Apr 2020
Executive Summary
RefleXion Medical Inc. (guided radiotherapy for cancer) raised $46mm through its Series B round from lead investor KCK Group and returning backers Pfizer Venture Investments, Venrock, and Sofinnova Partners. KCK takes two board seats. Funds will support continued development and expansion of the company's technologies that utilize positron emission tomography (PET) to guide radiotherapy treatment.
Deal Industry
- Medical Devices
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
RefleXion Medical closes $46mm Series B round; round extended to $52mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice